Intellia Therapeutics (NTLA) Amortizatization of Intangibles (2019 - 2025)

Historic Amortizatization of Intangibles for Intellia Therapeutics (NTLA) over the last 7 years, with Q3 2025 value amounting to $1.1 million.

  • Intellia Therapeutics' Amortizatization of Intangibles fell 7465.55% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.6 million, marking a year-over-year decrease of 5792.81%. This contributed to the annual value of $17.8 million for FY2024, which is 3120.05% down from last year.
  • Per Intellia Therapeutics' latest filing, its Amortizatization of Intangibles stood at $1.1 million for Q3 2025, which was down 7465.55% from $1.7 million recorded in Q2 2025.
  • Over the past 5 years, Intellia Therapeutics' Amortizatization of Intangibles peaked at $7.9 million during Q3 2023, and registered a low of -$2.6 million during Q4 2021.
  • Over the past 5 years, Intellia Therapeutics' median Amortizatization of Intangibles value was $1.7 million (recorded in 2025), while the average stood at $2.0 million.
  • As far as peak fluctuations go, Intellia Therapeutics' Amortizatization of Intangibles tumbled by 277945.21% in 2021, and later soared by 106152.91% in 2023.
  • Intellia Therapeutics' Amortizatization of Intangibles (Quarter) stood at -$2.6 million in 2021, then surged by 147.42% to $1.2 million in 2022, then surged by 404.96% to $6.3 million in 2023, then plummeted by 42.89% to $3.6 million in 2024, then plummeted by 69.88% to $1.1 million in 2025.
  • Its Amortizatization of Intangibles was $1.1 million in Q3 2025, compared to $1.7 million in Q2 2025 and $2.3 million in Q1 2025.